LACK OF EFFECT OF HISTOLOGICAL LESIONS ON THE PHENYTOIN AND PHENOBARBITAL CONCENTRATIONS IN THE BRAIN CORTEX OF EPILEPTIC PATIENTS

被引:5
作者
SCHNABEL, R
RAMBECK, B
MAY, TW
JURGENS, U
LAHL, R
VILLAGRAN, R
机构
[1] EPILEPSY RES FDN,DEPT BIOCHEM,D-33617 BIELEFELD,GERMANY
[2] EPILEPSY CTR BETHEL,INST NEUROPATHOL,D-33617 BIELEFELD,GERMANY
关键词
PHENYTOIN; PHENOBARBITAL; BRAIN CONCENTRATIONS; CORTICAL LESIONS; EPILEPSY; BINDING SITES;
D O I
10.1016/0022-510X(95)00197-A
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Postmortem concentrations of phenytoin (PHT) and phenobarbital (PB) were determined in 24 specimens of the frontal, temporal, occipital or neocerebellar cortex with different pathological changes and in the serum (total and free) from 11 epileptic patients. The cortical lesions were characterized by various degrees of neuronal loss or necrosis associated with other changes such as proliferated gliocytes, fibre gliosis, Rosenthal fibres or numerous corpora amylacea. According to other investigators neurons are the main binding sites of PHT and PB in rodent brains. The PHT and PB concentrations in 20 cortical lesions from nine patients were not significantly reduced as compared to the data of 46 deceased epileptic control patients. A significantly decreased PB value could only be demonstrated in the temporal specimen of an old scarred infarction with complete demyelination. On the other hand a slight but significant increase of PB was observed in three neocortical samples from a child exhibiting severe brain oedema and thrombosis of the sinuses. The results favour the unspecific binding of PHT and PB to cerebral tissue constituents and do not Support the hypothesis of major binding to specific receptors.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 19 条
[1]  
BOYKIN ME, 1976, J PHARMACOL EXP THER, V196, P469
[2]   ROSENTHAL FIBERS - AN IMMUNOHISTOCHEMICAL, ULTRASTRUCTURAL AND IMMUNOELECTRON MICROSCOPIC STUDY [J].
DINDA, AK ;
SARKAR, C ;
ROY, S .
ACTA NEUROPATHOLOGICA, 1990, 79 (04) :456-460
[3]   HUMAN-BRAIN PHENYTOIN - CORRELATION WITH UNBOUND AND TOTAL SERUM CONCENTRATIONS [J].
FRIEL, PN ;
OJEMANN, GA ;
RAPPORT, RL ;
LEVY, RH ;
VANBELLE, G .
EPILEPSY RESEARCH, 1989, 3 (01) :82-85
[4]  
GEARY WA, 1987, J PHARMACOL EXP THER, V241, P704
[5]   BINDING OF DIPHENYLHYDANTOIN TO BRAIN PROTEIN [J].
GOLDBERG, MA ;
TODOROFF, T .
BIOCHEMICAL PHARMACOLOGY, 1973, 22 (23) :2973-2980
[6]  
GOLDBERG MA, 1980, ANTIEPILEPTIC DRUGS, P501
[7]  
JURGENS U, 1987, J LIQ CHROMATOGR, V10, P1847
[8]  
KEMP JW, 1971, J PHARMACOL EXP THER, V177, P342
[9]  
LAHL R, 1993, ANFALLSKRANKHEITEN I, P108
[10]   BINDING OF DIPHENYLHYDANTOIN TO BRAIN AND SUBCELLULAR FRACTIONS [J].
NIELSEN, T ;
COTMAN, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1971, 14 (04) :344-&